Rene M. Lemieux

Rene M. Lemieux possesses extensive experience in the pharmaceutical and biotechnology sectors, holding significant leadership roles such as Head of Drug Discovery Sciences at Avilar Therapeutics and Senior Vice President, Head of Drug Discovery at Faze Medicines. Rene established Tetrahedral Consulting LLC as Owner & Principal and serves as an SAB Member at Immugenia Inc. Additionally, Rene held the position of Vice President, Head of Small Molecule Drug Discovery at KSQ Therapeutics, Inc. Academic qualifications include a Ph.D. in Organic Chemistry from The University of British Columbia and a B.Sc. in Chemistry from Université de Sherbrooke.